Home › Funds › Deep Track Capital, LP › LBRX

Deep Track Capital, LP position in LBRX

LB PHARMACEUTICALS INC · Health Care

Deep Track Capital, LP reported holding 3,352,804 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$108.8M, representing 1.62% of its reported portfolio and ranking #27 among its reported holdings. Deep Track Capital, LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)3.35M sh
Reported value held$108.82M
Portfolio Weight1.62%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's LBRX position evolved

Deep Track Capital, LP first disclosed a stake in LBRX in Q3 2025 at 3,352,804 shares (US$52.9M). The position peaked in Q2 2026 at 3,352,804 shares, worth US$108.8M. Across 4 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,352,804 shares valued at US$108.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.35M $52.94M New
Q4 2025 3.35M $74.63M Hold
Q1 2026 3.35M $82.68M Hold
Q2 2026 3.35M $108.82M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M), Commodore Capital LP (US$48.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has Deep Track Capital, LP held LBRX?

Deep Track Capital, LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Deep Track Capital, LP's current position in LBRX?

As of Q2 2026, Deep Track Capital, LP holds 3.35M shares of LBRX (LB PHARMACEUTICALS INC), valued at $108.82M, representing 1.62% of its reported portfolio and ranking #27.

Has Deep Track Capital, LP been buying or selling LBRX?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP held unchanged its position in LBRX. The position peaked in Q2 2026 at 3.35M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, Commodore Capital LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.